Income before deduction of interest, taxes and amortization: Neurogene (NGNE)
Neurogene Inc. maintains pricing power through its EXACT platform, which safely regulates gene expression. High R&D costs and patents create a formidable moat against competition. The monthly EBITDA trend captures the impact of these factors, and 0.00 becomes the new value for this metric. This confirms the growth potential in the rare neurological pathology market, where there is an acute shortage of effective therapies.
Summary analytical data breakdowns for Neurogene (NGNE)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
- earnings and market multiples details:
NGNE - Company Net Income|Net Profit Forecast Neurogene Inc.|NGNE - P/E Multiple|Projected Price to Earnings neurogene.com|NGNE - Price/Earnings to Growth Multiple|Total Company Value to Operating Income Before Depreciation Ratio Neurogene|NGNE - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Neurogene|NGNE - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year neurogene.com|NGNE - Earnings per share growth in current year|Projected earnings per share growth rate for next year Neurogene Inc.
Summary company analytics:Neurogene Inc.
High barriers to entry in the gene therapy segment protect the developments of Neurogene Inc. (NGNE) from replication, transforming scientific patents into a strategic asset. By analyzing the EBITDA level, an investor assesses the efficiency of the core business without the influence of debt load and depreciation, which allows for the separation of fundamental cash flow from market speculation and the determination of the company's fair value.
Competitor analysis for Neurogene Inc.
Operating profit EBITDA Biogen Idec BIIB|NBIX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization RGC (regencellbioscience.com)|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization ACADIA Pharma (ACAD)|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|VKTX - Operating profit before depreciation charges|Operating profit EBITDA SUPN|CPRX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|HRMY: Operating profit before amortization|Biohaven Pharmaceutical - Operating profit EBITDA|Profit before interest, taxes and amortization Amylyx Corp|TRVI (Trevi Therapeutics) - Operating profit before deduction of amortization|praxismedicines.com - Income before deduction of interest, taxes and amortization|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|CeriBell Inc (CBLL) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|alector.com - Operating profit before amortization|Operating profit EBITDA ANNX (Annexon, Inc.)|OMER - Operating profit before deduction of amortization|ACIU: Operating profit before deduction of amortization|Operating income before deduction of amortization Voyager Therapeutics Inc VYGR|Neumora Therapeutics Inc (NMRA) - Profit before payment of interest, taxes and amortization|Operating profit before amortization SCLX|TVGN (Tevogen Bio Holdings) - Operating profit EBITDA|ACOG - Operating profit before depreciation charges|Profit before payment of interest, taxes and amortization Cognition Therapeutics, Inc. (CGTX)|Inhibikase Therapeutics Inc - Operating profit before amortization|Operating profit EBITDA SAVA (Cassava)|Assertio Holdings (ASRT) - Profit before interest, taxes and amortization|COYA - Profit before payment of interest, taxes and amortization|VTGN (Vistagen Therapeutics) - Operating profit before amortization|OVID: Operating profit EBITDA|Profit before interest, taxes and amortization Acumen Pharmaceuticals Inc. (ABOS)|Operating profit before deduction of amortization CRVO|Operating profit EBITDA Alterity Therapeutics Ltd|Profit before payment of interest, taxes and amortization Clene Inc. (CLNN)|PEPG (pepgen.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|Relmada Therapeutics Inc (RLMD) - Profit before interest, taxes and amortization|ANVS - Profit before payment of interest, taxes and amortization|GRCE (Grace Therapeutics, Inc.) - Operating profit before amortization|AIFF: Operating profit EBITDA|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|Operating profit before deduction of amortization NRSN|Operating profit EBITDA Reviva Pharmaceuticals Holdings Inc.|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS (NeurAxis Inc) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|Passage Bio Inc. (PASG) - Profit before interest, taxes and amortization|Neuphoria - Operating profit EBITDA|Operating profit before depreciation charges Minerva Neurosciences Inc (NERV)|ATHA: Operating profit EBITDA|Profit before interest, taxes and amortization Addex (ADXN)|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Operating profit before amortization CYCN (Cyclerion)|Operating profit EBITDA PTIX|KTTA - Profit before interest, taxes and amortization|Cortigent - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization ATXI|Brainstorm Cell - Operating profit EBITDA|Operating income before deduction of amortization caratherapeutics.com CARA|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ELYM|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Longboard (LBPH)|Operating profit before deduction of amortization MRNS (Marinus Pharmaceuticals)|Operating income before deduction of amortization nkgenbiotech.com|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|SAGE: Operating profit before amortization|Neurotrope - Operating profit EBITDA|Operating profit before depreciation charges Trevena Inc (TRVN)|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|Operating profit before amortization WENA|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
